Investigational Drug Information for Theanine
✉ Email this page to a colleague
What is the development status for investigational drug Theanine?
Theanine is an investigational drug.
There have been 3 clinical trials for Theanine.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 18th 2019.
The most common disease conditions in clinical trials are Problem Behavior, Mental Disorders, and Hyperkinesis. The leading clinical trial sponsors are University of British Columbia, Icahn School of Medicine at Mount Sinai, and Butler Hospital.
Summary for Theanine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,433 |
| WIPO Patent Applications | 1,090 |
| Japanese Patent Applications | 107 |
| Clinical Trial Progress | Phase 2 (2019-10-18) |
| Vendors | 0 |
Recent Clinical Trials for Theanine
| Title | Sponsor | Phase |
|---|---|---|
| Effects of L-theanine on Motor Cortex Excitability in Healthy Subjects: A Paired-Pulse TMS Study | Butler Hospital | Early Phase 1 |
| Assessing the Effectiveness of an N-of-1 Platform Using Study of Cognitive Enhancers | Icahn School of Medicine at Mount Sinai | Phase 4 |
| Effects of L-Theanine in Boys With ADHD | University of British Columbia | Phase 2 |
Clinical Trial Summary for Theanine
Top disease conditions for Theanine
Top clinical trial sponsors for Theanine
US Patents for Theanine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
